HIGH

Merck Recalls Belsomra Tablets Due to Dissolution Issues

Merck Sharp & Dohme LLC recalled 51,320 cartons of Belsomra (suvorexant) tablets on July 21, 2025. The recall stems from a failure in dissolution specifications that could delay drug release. Consumers should stop using the product immediately and consult healthcare providers for guidance.

Quick Facts at a Glance

Recall Date
July 21, 2025
Hazard Level
HIGH
Brands
BELSOMRA, Merck Sharp & Dohme LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Merck & Co. Inc or your healthcare provider for guidance. Notification method: N/A

Product Details

The recall involves Belsomra (suvorexant) tablets, 10mg, packaged in 30 tablets per carton with 3 blister cards. The affected lot numbers are 2090019 and 2123744, with an expiration date of April 30, 2027.

The Hazard

The product may exhibit delayed dissolution after administration, potentially delaying the onset of sleep. This issue falls under Class II recall due to associated risks.

Reported Incidents

No specific incidents of injury or adverse events linked to this recall have been reported yet. Monitoring for any such reports will continue.

What to Do

Consumers and healthcare providers should stop using Belsomra immediately. For further guidance, contact Merck & Co. Inc.

Contact Information

For more information, visit the FDA's recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0584-2025.

Key Facts

  • Product: Belsomra (suvorexant) tablets, 10mg
  • Quantity recalled: 51,320 cartons
  • Recall date: July 21, 2025
  • Classification: Class II recall
  • Hazard: Potential delayed drug release

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeSuvorexant Tablets
Sold At
Multiple Retailers

Product Details

Model Numbers
Lots 2090019 and 2123744
Exp. 4/30/2027
UPC Codes
0006-0005
0006-0033
0006-0325
+11 more
Affected States
ALL
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more